Cytokine profile of a long-term pediatric HIV survivor with hyper-IgE syndrome and a normal CD4+ T-cell count

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 1045-1051

  Seroogy, Christine M ^a,c   Wara, Diane W ^a   Bluth, Martin H ^b   Dorenbaum, Alejandro ^a   White, Carmen ^a   Durkin, Helen G ^b   Elder, Melissa E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Anti HIV IgE; Cytokine; HIV; Hyper IgE syndrome; T(H1); T(H2)

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; PHORBOL 13 ACETATE 12 MYRISTATE; VIRUS PROTEIN;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERIMMUNOGLOBULINEMIA E; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0032711690     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70087-4     Document Type: Article

References (50)

1. 1. Duliege AM, Messiah A, Blanche S, Tardieu M, Griscelli C, Spira A. Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease. Pediatr Infect Dis J 1992;11:630-5.
2. 2. Scott GB, Hutto C, Makuch RW, Mastrucci MT, O'Connor T, Mitchell CD, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-6.
3. 3. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997;336:1337-42.
4. 4. Small CB, McGowan JP, Klein RS, Schnipper SM, Chang CJ, Rosenstreich DL. Serum IgE levels in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 1998;81:75-80.
5. 5. Agarwal SK, Marshall GD. In vivo alteration in type-1 and type-2 cytokine balance: a possihle mechanism for elevated total IgE in HIV-infected patients. Hum Immunol 1998;59:99-105.
6. 6. Israel-Biet D, Labrousse F, Tourani JM, Sors H, Andrieu JM, Even P. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J Allergy Clin Immunol 1992;89:68-75.
7. + T-cells. AIDS Res Hum Retroviruses 1990;6:427-9.
8. 8. Wright DN, Nelson RP, Ledford DK, Fernandez-Caldas E, Trudeau WL, Lockey RF. Serum IgE and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1990;85:445-52.
9. 9. Vigano A, Principi N, Villa ML, Riva C, Crupi L, Trabattoni D, et al. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. J Pediatr 1995;126:368-74.
10. 10. Hyjek E, Lischner HW, Hyslop T, Bartkowiak J, Kubin M, Trinchieri G. et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol 1995;155:4060-71.
11. 11. Vigano A, Principi N. Crupi L, Onoralo J, Vincenzo ZG, Salvaggio A. Elevation of IgE in HIV-infected children and its correlation with the progression of disease. J Allergy Clin Immunol 1995;95:627-32.
12. 12. Vigano A, Balotta C, Trabattoni D, Bricalli D, Crupi L, Palomba E, et al. Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts. Pathobiology 1997;65:169-76.
13. 13. Ellaurie M, Rubinstein A, Rosenstreich DL. IgE levels in pediatric HIV-1 infection. Ann Allergy Asthma Immunol 1995;75:332-6.
14. 14. Paganelli R, Scala E, Ansotegui IJ, Mezzaroma I, Pinter E, Ferrara R, et al. Hyper IgE syndrome induced by HIV infection. Immunodeficiency 1993;4:149-52.
15. 15. Paganelli R, Scala E, Mezzaroma I, Pinter E, D'Offizi G, Fanales-Belasio E, et al. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995;95:995-1003.
16. 16. Paganelli R, Scala E, Mazzone AM, Rosso R, Mattiacci G, Dell' Anna I., et al. Th2-type cytokines, hypercosinophilia, and interleukin-5 in HIV disease. Allergy 1997;52:110-1.
17. 17. Bacot BK, Paul ME, Navarro M, Abramson SL, Kline MW, Hanson IC, et al. Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol 1997;100:707-11.
18. 18. Koutsonikolis A, Nelson RP Jr, Fernandez-Caldas E, Brigino EN, Seleznick M, Good RA, et al. Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol 1996;97:692-7.
19. 19. Haanen JB, de Waal Malefijt R, Res PC, Kraakman EM, Ottenhoff TH, de Vries RR, et al. Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 1991;174:583-92.
20. 20. Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88:4538-42.
21. 21. Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RA, Kapsenberg ML. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991;147:2942-9.
22. 22. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991;174:593-601.
23. 23. Constant SL, Botlomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997;15:297-322.
24. 24. Clerici M, Shearer GM. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-11.
25. 25. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
26. 26. Elder ME, Hope TJ, Parslow TG, Umetsu DT, Wara DW, Cowan MJ. Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency. Cell Immunol 1995;165:110-7.
27. 27. Secord EA, Kleiner GI, Auci DL, Smith-Horowitz T, Chice S, Finkielstein A, et al. IgE against HIV proteins in clinically healthy children with HIV disease. J Allergy Clin Immunol 1996;98:979-84.
28. 28. Martin NL, Levy JA, Legg H, Weintrub PS, Cowan MJ, Wara DW. Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins. J Pediatr 1991;118:354-8.
29. 29. McElrath MJ, Siliciano RF, Weinhold KJ. HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation. AIDS Res Hum Retroviruses 1997;13:211-6.
30. 30. Buckley RH, Becker WG. Abnormalities in the regulation of human IgE synthesis. Immunol Rev 1978;41:288-314.
31. 31. Buckley R, Stiehm ER. Immunologic disorders in infants and children. 3rd ed. Philadelphia: W.B. Saunders; 1988.
32. 32. Paganelli R, Scala E, Ansotegui IJ, Ausiello CM, Halapi E, Fanales-Belasio E, et al. CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med 1995;181:423-8.
33. 33. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
34. 34. Cao Y. Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
35. 35. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997;337:1267-74.
36. 36. McMichael A, Koup R, Ammann AJ. Transient HIV infection in infants [letter]. N Engl J Med 1996;334:801-2.
37. 37. Barker E, Mackewicz CE, Levy JA. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 1995;92:11135-9.
38. 38. Swain SL. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1994;1:543-52.
39. 39. Maggi E, Mazzetti M, Ravina A, Annunziato F, de Carli M, Piccinni MP, et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994;265:244-8.
40. 40. Romagnani S, Del Prete G, Manetti R, Ravina A, Annuziato F, De Carli M, et al. Role of TH1/TH2 cytokines in HIV infection. Immunol Rev 1994;140:73-92.
41. 41. Pellegrino MG, Bluth MH, Secord E, Nowakowski M, Kleiner G, Fikrig S, et al. HIV-1-specific IgE in sera of HIV-1-infected children has HIV-1 inhibitory activity in vitro: Correlation to healthy status. XI International Conference on AIDS; 1996; Vancouver, Canada. #WE.B. 3324.
42. 42. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
43. 43. Lee B, Doranz BJ, Rana S, Yi Y, Mellado M, Frade JM, et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 1998;72:7450-8.
44. 44. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998;4:786-93.
45. 45. Jourdan P, Abbal C, Nora N, Hori T, Uchiyama T, Vendrell JP, et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol 1998;160:4153-7.
46. 46. Kinter AL, Ostrowski M, Goletti D, Oliva A, Weissman D, Gantt K, et al. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996;93:14076-81.
47. 47. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-5.
48. 48. Rodriguez MF, Patino PJ, Montoya F, Montoya CJ, Sorensen RU, Garcia de Olarte D. Interleukin 4 and interferon-gamma secretion by antigen and mitogen-stimulated mononuclear cells in the hyper-IgE syndrome: no TH-2 cytokine pattern. Ann Allergy Asthma Immunol 1998;81:443-7.
49. 49. Rich R. Clinical immunology: principles and practice. St Louis: Mosby; 1996. p. 615.
50. 50. Rich R. Clinical immunology: principles and practice. St Louis: Mosby; 1996. p. 2172.